|
MGAT5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.08729963605492E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.54730006585169E-10 |
| Normal-vs-Stage2 |
4.15169999490317E-08 |
| Normal-vs-Stage3 |
1.189640E-04 |
| Normal-vs-Stage4 |
6.35209999999553E-05 |
| Stage1-vs-Stage2 |
1.556850E-01 |
| Stage1-vs-Stage3 |
1.860980E-01 |
| Stage1-vs-Stage4 |
8.138400E-01 |
| Stage2-vs-Stage3 |
6.277200E-01 |
| Stage2-vs-Stage4 |
6.264600E-01 |
| Stage3-vs-Stage4 |
5.407800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
3.24629989556513E-10 |
| Normal-vs-Asian |
6.29380003669411E-09 |
| Caucasian-vs-AfricanAmerican |
8.234200E-01 |
| Caucasian-vs-Asian |
1.497640E-01 |
| AfricanAmerican-vs-Asian |
3.886200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0683998130645E-10 |
| Normal-vs-Female |
7.87870000018565E-07 |
| Male-vs-Female |
1.438070E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.27199997388561E-09 |
| Normal-vs-Extreme_Weight |
2.96570545899044E-11 |
| Normal-vs-Obese |
2.93750024304984E-10 |
| Normal-vs-Extreme_Obese |
1.47300005526319E-09 |
| Normal_Weight-vs-Extreme_Weight |
1.255760E-01 |
| Normal_Weight-vs-Obese |
7.188200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.914600E-01 |
| Extreme_Weight-vs-Obese |
1.461870E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.166400E-01 |
| Obese-vs-Extreme_Obese |
1.150990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.130140E-02 |
| Normal-vs-Age(41-60Yrs) |
1.06950004408191E-09 |
| Normal-vs-Age(61-80Yrs) |
1.97399985246705E-10 |
| Normal-vs-Age(81-100Yrs) |
2.88890023014687E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.113200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.621400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.415640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.585240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.415960E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.345370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.88740192550586E-11 |
| Normal-VS-Type2 PRCC |
7.26974036524553E-13 |
| Normal-VS-KIRP CIMP |
4.504200E-01 |
| Normal-VS-Unclassified PRCC |
1.15129999977981E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.221420E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.206200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.002100E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.156630E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.779220E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.115800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.7973955657169E-11 |
| Normal-vs-N1 |
1.841570E-03 |
| Normal-vs-N2 |
9.567600E-02 |
| N0-vs-N1 |
9.576100E-02 |
| N0-vs-N2 |
3.583200E-01 |
| N1-vs-N2 |
7.739800E-01 |
|
|
